Core B: Developmental core

核心B:发展核心

基本信息

  • 批准号:
    10090663
  • 负责人:
  • 金额:
    $ 43.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-03 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

CORE B: Abstract/Summary The Developmental Core (Core B) supports the overall mission of the PMHARC through its services focused on training, mentoring, and management of the pilot projects program. During the current funding cycle, Core B, in partnership with the Administrative Core and the PMHARC Executive Committee (EC) established a rigorous, efficient strategy for the solicitation and review of high priority pilot research focused on mental illness and HIV/AIDS. The role of the pilot projects program within the PMHARC is central to its overall mission and provides the framework for the delivery of much of the Center's training and mentoring services. Pilots are expected to pair experienced investigators with early career or transitional investigators. All Cores are expected to assist with the development of pilot concepts and proposals and if selected for funding, provide services to the pilot investigators and their projects at no cost, adding real value to each pilot. During this first funding cycle, the PMHARC invested 10% of its annual total costs to support pilot projects and a total of 26 projects have been funded thus far with support of up to $40,000 each. In all of the Core's services, priority is given to early career investigators and investigators from underrepresented racial and ethnic groups. Forty-four early career and transitioning investigators have been engaged in pilot projects thus far, 21% are from racial and ethnic minority groups and 61% are women. To assist with the recruitment of participants for the pilot projects, the Core established the bi-weekly recruitment support group. As a result of the success of this group in assisting with recruitment for HIV/AIDS research beyond the pilots, this service transitioned to become an ongoing service of the Community Engagement Core. During the current funding cycle, the Developmental Core established the monthly PMHARC Journal Club that provides a forum for presentation and discussion of significant research focused on mental illness and HIV/AIDS. The Journal Club is also used as a venue for pilot investigators to present findings, receive feedback on interpretation of data, plan for publication and subsequent grant submissions, and practice presentation skills. Core B also led the development and implementation of the first city-wide conference designed to increase awareness of HIV research taking place in Philadelphia and to promote research collaborations. The serves as a clearinghouse for related seminars and trainings offered both on and off campus. During the next funding cycle, we will build on the success of the pilot projects program by working with seven other centers and institutes on campus to co-sponsor pilot projects, expanding the scientific reach of the PMHARC and providing increased funds for larger projects. As more pilots are completed, there will be an increased opportunity to promote publication of findings and grant applications. The Core will continue to facilitate mentoring relationships and collaborations and provide ongoing monitoring and evaluation of the pilot projects program.
核心B:摘要/总结 发展核心(核心B)通过其重点服务支持PMHARC的总体使命 培训、指导和管理试点项目。在本供资周期,核心 B与行政核心和PMHARC执行委员会(EC)合作, 严格、有效的战略,以征求和审查高度优先的试点研究,重点是精神疾病 和艾滋病毒/艾滋病PMHARC内试点项目计划的作用是其总体使命的核心 为中心的大部分培训和指导服务的交付提供了框架。飞行员 预计将有经验的调查人员与早期职业或过渡调查人员配对。所有核心都是 预计将协助制定试点概念和提案,如果被选中提供资金, 免费为试点调查员及其项目提供服务,为每个试点增加真实的价值。在该第一 在资助周期内,PMHARC将其年度总成本的10%用于支持试点项目, 到目前为止,每个项目的资助额最高可达40 000美元。在核心的所有服务中,优先级是 给予早期职业调查人员和来自代表性不足的种族和民族群体的调查人员。四十四 到目前为止,早期职业和过渡期调查人员已经参与了试点项目,21%来自种族 和少数民族群体,61%是妇女。协助为试点项目招募参与者 在项目期间,核心小组设立了双周征聘支助小组。由于这个团体的成功, 在协助招募艾滋病毒/艾滋病研究人员方面,这项服务已经转变为一项 社区参与核心的持续服务。在当前的融资周期内, 核心建立了每月一次的PMHARC期刊俱乐部,为介绍和讨论 重要的研究集中于精神疾病和艾滋病毒/艾滋病。杂志俱乐部也被用作试点场地 研究人员提交研究结果,接受对数据解释的反馈,计划发表, 随后的赠款提交,并练习演讲技巧。核心B也引领了开发, 举办第一次全市性会议,以提高人们对正在进行的艾滋病毒研究的认识 在费城,并促进研究合作。作为相关研讨会的信息交流中心 以及校内和校外提供的培训。在下一个融资周期,我们将在 通过与校园内的其他七个中心和研究所合作,共同赞助试点项目, 项目,扩大PMHARC的科学范围,并为更大的项目提供更多的资金。作为 更多的试点项目完成后,将有更多的机会促进公布研究结果和赠款 应用.核心将继续促进指导关系和合作,并提供 不断监测和评估试点项目方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S METZGER其他文献

DAVID S METZGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S METZGER', 18)}}的其他基金

Administrative Core A
行政核心A
  • 批准号:
    10891051
  • 财政年份:
    2023
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10197865
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10436808
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10654008
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10004224
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
快速启动丁丙诺啡/纳洛酮以优化费城 MAT 的利用
  • 批准号:
    9896726
  • 财政年份:
    2018
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    7835556
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8261981
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    7687184
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8085908
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了